TY - JOUR
T1 - OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: Chest X-ray or ultra-low-dose chest CT (OPTIMACT) trial - Statistical analysis plan
AU - Kanglie, Maadrika M. N. P.
AU - Bipat, Shandra
AU - van den Berk, Inge A. H.
AU - van Engelen, Tjitske S. R.
AU - Dijkgraaf, Marcel G. W.
AU - Prins, Jan M.
AU - Stoker, Jaap
AU - Bossuyt, Patrick M. M.
PY - 2020/5/14
Y1 - 2020/5/14
N2 - Background: A chest X-ray is a standard imaging procedure in the diagnostic work-up of patients suspected of having non-traumatic pulmonary disease. Compared to a chest X-ray, an ultra-low-dose (ULD) chest computed tomography (CT) scan provides substantially more detailed information on pulmonary conditions. To what extent this translates into an improvement in patient outcomes and health care efficiency is yet unknown. The OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose chest CT (OPTIMACT) study is a multicenter, pragmatic, non-inferiority randomized controlled trial designed to evaluate replacement of chest X-ray by ULD chest CT in the diagnostic work-up of such patients, in terms of patient-related health outcomes and costs. During randomly assigned periods of 1 calendar month, either conventional chest X-ray or ULD chest CT scan was used as the imaging strategy. This paper presents in detail the statistical analysis plan of the OPTIMACT trial, developed prior to data analysis. Methods/results: Functional health at 28 days is the primary clinical outcome. Functional health at 28 days is measured by the physical component summary scale of the Short Form (SF)-12 questionnaire version 1. Secondary outcomes are mental health (mental component summary scale of the SF-12), length of hospital stay, mortality within 28 days, quality-adjusted life year equivalent during the first 28 days (derived from the EuroQol five-dimension, five-level instrument), correct diagnoses at emergency department discharge as compared to the final post hoc diagnosis at day 28, number of patients in follow-up because of incidental findings on chest X-ray or ULD chest CT, and health care costs. Conclusions: After this pragmatic trial we will have precise estimates of the effectiveness of replacing chest X-ray with ULD chest CT in terms of patient-related health outcomes and costs. Trial registration: Netherlands National Trial Register: NTR6163. Registered on 6 December 2016.
AB - Background: A chest X-ray is a standard imaging procedure in the diagnostic work-up of patients suspected of having non-traumatic pulmonary disease. Compared to a chest X-ray, an ultra-low-dose (ULD) chest computed tomography (CT) scan provides substantially more detailed information on pulmonary conditions. To what extent this translates into an improvement in patient outcomes and health care efficiency is yet unknown. The OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose chest CT (OPTIMACT) study is a multicenter, pragmatic, non-inferiority randomized controlled trial designed to evaluate replacement of chest X-ray by ULD chest CT in the diagnostic work-up of such patients, in terms of patient-related health outcomes and costs. During randomly assigned periods of 1 calendar month, either conventional chest X-ray or ULD chest CT scan was used as the imaging strategy. This paper presents in detail the statistical analysis plan of the OPTIMACT trial, developed prior to data analysis. Methods/results: Functional health at 28 days is the primary clinical outcome. Functional health at 28 days is measured by the physical component summary scale of the Short Form (SF)-12 questionnaire version 1. Secondary outcomes are mental health (mental component summary scale of the SF-12), length of hospital stay, mortality within 28 days, quality-adjusted life year equivalent during the first 28 days (derived from the EuroQol five-dimension, five-level instrument), correct diagnoses at emergency department discharge as compared to the final post hoc diagnosis at day 28, number of patients in follow-up because of incidental findings on chest X-ray or ULD chest CT, and health care costs. Conclusions: After this pragmatic trial we will have precise estimates of the effectiveness of replacing chest X-ray with ULD chest CT in terms of patient-related health outcomes and costs. Trial registration: Netherlands National Trial Register: NTR6163. Registered on 6 December 2016.
KW - Chest X-ray
KW - Emergency department
KW - Microdose chest CT
KW - Non-traumatic chest disease
KW - Non-traumatic pulmonary disease
KW - Pulmonary disease
KW - Statistical analysis plan
KW - ULD chest CT
KW - Ultra-low-dose chest CT
UR - http://www.scopus.com/inward/record.url?scp=85085140554&partnerID=8YFLogxK
U2 - https://doi.org/10.1186/s13063-020-04343-w
DO - https://doi.org/10.1186/s13063-020-04343-w
M3 - Article
C2 - 32410657
SN - 1745-6215
VL - 21
JO - Trials
JF - Trials
IS - 1
M1 - 407
ER -